DOSSIER · 13F Holders · Q2 2026
AKTS
AKTIS ONCOLOGY INC
110 institutions still hold AKTIS ONCOLOGY INC as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 01021M104·110 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
110 institutions reported AKTS in Q2 2026. MPM BioImpact LLC leads at 16.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 6
90 more holders available. Log in →